Q32 Bio Inc. Common Stock
QTTBQ32 Bio Inc. is a biotechnology company focused on developing novel therapies for rare and underserved diseases. The company leverages its expertise in drug discovery and development to create innovative treatments aimed at improving patient outcomes.
$3.32 -0.16 (-4.82%)
Company News
Why Is Small-Cap Q32 Bio Stock Soaring On Monday?
Q32 Bio sold its Phase 2 complement inhibitor ADX-097 to Akebia Therapeutics for $12 million in upfront payments, with potential milestone payments up to $592 million, causing its stock to surge by over 115%.
